Z-FIX
100 mg/ 5 mL Powder for Oral Suspension
Cefixime is bactericidal and is stable to hydrolysis by many beta-lactamase. It has mode of action and spectrum of activity similar to that of the third generation cephalosporin cefotaxime, but some enterobacteriaceae are less susceptible to Cefixime. Haemophilus influenza, Moraxella catarrhalis (Branhamella catarrhalis) and Neisseria gonorrhoea are sensitive, including penicillinase-producing strains of the Gram-positive bacteria, Streptococci are sensitive to Cefixime but most strains of Staphylococci, Enterococci and Listeria spp. are not. Enterobacter spp., Pseudomonas aeruginosa, and Bacteroides spp. are resistant to Cefixime.
For the treatment of infections due to sensitive Gram-positive and Gram-negative bacteria.
Only 40 to 50% of an oral dose of Cefixime is absorbed from the gastrointestinal tract, whether taken before or after meals, although the rate of absorption may be decreased in the presence of food. Cefixime is better absorbed from oral suspension than from tablets. Absorption is fairly slow; peak plasma concentrations of 2 to 3 mcg/ mL and 3.7 to 4.6 mcg/ mL have been reported between 2 and 6 hours after single doses of 200 and 400 mg, respectively. The plasma half-life is usually about 3-4 hours and may be prolonged when there is renal impairment. About 65% of Cefixime is bound to plasma proteins. Information on the distribution of Cefixime in body tissues and fluids is limited. It crosses the placenta. Relatively high concentrations may be achieved in bile and urine. About 20% of an oral dose (or 50% of an absorbed dose) is excreted unchanged in the urine within 24 hours. Up to 6% may be eliminated by non-renal mechanism; there is no evidence of metabolism but some is probably excreted in the feces from bile. It is not substantially removed by dialysis.
Children over 6 months | 8 mg/ kg daily in 1 to 2 divided doses |
6 months up to 1 year | 7.5 mL daily |
Children 1 to 4 years | 10 mL daily |
Children 5 to 10 years | 20 mL daily |
The usual course of treatment is 7 days. This may be continued for up to 14 days if required or as prescribed by the physician
Although cefixime does not have the N-methylthiotetrazole side-chain usually associated with hypoprothrombinemia, increases in prothrombin times have occurred in a few patients.
Check out our available products
ZIPHANOL
Therapeutic Indication Dosage Forms Bioavailability and Pharmacokinetics Dose Range Known Adverse Effects and Toxicities Special Precautions Therapeutic Indication Therapeutic Indication Moderate to severe pain of any form, particularly visceral pain; perioperative analgesia....
NIRPID 10
Dosage Strength & Form Descripton Pharmacology Indications Contraindications Warning Precautions Caution Adverse Reactions Dosage Infusion Rate Administration Overdosage Storage Presentation Dosage Strength & Form Dosage Strength & Form 10g/100ml (10%w/v) Fat Emulsion...
K5 LIPOGEL
PACKAGE SIZE & TYPE COMPOSITION DESCRIPTION SUGGESTED USE CAUTION PACKAGE SIZE & TYPE 40 ml Tube COMPOSITION Dicaprylyl Ether, C12-15 Alkyl Benzoate, Cyclopentasiloxane, Zea mays (Corn) Starch, Pidobenzone, Ethylhexyl Methoxycinnamate, (Octyl Methoxycinnamate),...
Get In Touch
For questions, inquiry or to know more about our products, please feel free to call us at +63 052 742-2844 / +63 02 829-0181, email us at zyrepharma@yahoo.com or click the button below.
Contact Us